Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance
- 13 January 2003
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 100 (3), 833-838
- https://doi.org/10.1073/pnas.0336235100
Abstract
The nuclear receptor PXR (pregnane X receptor) is a broad-specificity sensor that recognizes a wide variety of synthetic drugs and xenobiotic agents. On activation by these compounds, PXR coordinately induces a network of transporters, cytochrome P450 enzymes, and other genes that effectively clear xenobiotics from the liver and intestine. Like PXR, the majority of its target genes also possess a broad specificity for exogenous compounds. Thus, PXR is both a sensor and effector in a well integrated and generalized pathway for chemical immunity. Although it is clear that PXR responds to numerous foreign compounds, it is unclear whether it possesses an endogenous ligand. To address this issue, we noted that there is substantial overlap in the substrate specificities of PXR and its critical CYP3A target gene. This prompted us to ask whether endogenous CYP3A substrates also serve as PXR ligands. We demonstrate that 5beta-cholestane-3alpha,7alpha,12alpha-triol (triol), a cholesterol-derived CYP3A substrate, is a potent PXR agonist that effectively induces cyp3a expression in mice. This defines a critical salvage pathway that can be autoinduced to minimize triol accumulation. In contrast, triol can accumulate to very high levels in humans, and unlike mice, these people develop the severe clinical manifestations of cerebrotendinous xanthomatosis. The reason for these dramatic species differences has remained unclear. We now demonstrate that triol fails to activate human PXR or induce the CYP3A-salvage pathway. This explains why humans are more susceptible to sterol accumulation and suggests that synthetic ligands for human PXR could be used to treat cerebrotendinous xanthomatosis and other disorders of cholesterol excess.Keywords
This publication has 28 references indexed in Scilit:
- Vitamin D Receptor As an Intestinal Bile Acid SensorScience, 2002
- The Nuclear Receptor PXR: A Master Regulator of “Homeland” DefenseCritical Reviews™ in Eukaryotic Gene Expression, 2002
- Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXRPublished by Elsevier BV ,2001
- Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27 Mice but Not in Cerebrotendinous XanthomatosisJournal of Biological Chemistry, 2001
- Humanized xenobiotic response in mice expressing nuclear receptor SXRNature, 2000
- The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during EvolutionMolecular Endocrinology, 2000
- Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- PHENOTYPIC STABILITY OF ADULT RAT HEPATOCYTES IN PRIMARY MONOLAYER CULTURE*Annals of the New York Academy of Sciences, 1980
- Hormones and ResistanceJournal of Pharmaceutical Sciences, 1971